Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.38
Delayed Data
As of 2:06pm ET
 0.00 / 0.00%
Today’s Change
1.63
Today|||52-Week Range
16.83
-67.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues25.8M11.0M4.6M4.8M
 
 
 
 
 
Cost of Goods Sold393.0K1.3M6.5K30.0K
 
 
 
 
 
Depreciation And Amortization49.0K43.0K43.0K47.0K
 
 
 
 
 
 
Operating ExpensesGross Income25.4M9.6M4.6M4.7M
 
 
 
 
 
General Expenses20.1M22.8M21.7M23.8M
 
 
 
 
 
Research And Development16.5M20.1M19.0M20.6M
 
 
 
 
 
Total Operating Expenses20.5M24.1M21.8M23.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income5.3M-13.2M-17.2M-19.0M
 
 
 
 
 
Extraordinary Credit749.0K0.00229.0K0.00
 
 
 
Extraordinary Charge0.00-452.0K0.00-2.8M
 
 
 
Interest Expense On Debt1.3M1.2M1.3M1.5M
 
 
 
 
 
Other Expenses0.00100.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.9M-14.6M-18.1M-22.8M
 
 
 
 
 
Net Income4.9M-14.6M-18.1M-22.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.6M73.3M73.3M73.6M
 
 
 
 
 
Shares To Calculate EPS Diluted76.8M73.3M73.3M73.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.06-$0.20-$0.25-$0.31
 
 
 
 
 
EPS Diluted$0.06-$0.20-$0.25-$0.31